机译:靶向MDR1的复制型腺病毒与化学疗法联合治疗卵巢癌
Department of Obstetrics and Gynecology, University of Düsseldorf Medical Center, Moorenstrasse 5, 40225, Düsseldorf, Germany;
Department of Obstetrics and Gynecology, University of Düsseldorf Medical Center, Moorenstrasse 5, 40225, Düsseldorf, Germany;
Department of Obstetrics and Gynecology, University of Düsseldorf Medical Center, Moorenstrasse 5, 40225, Düsseldorf, Germany;
Department of Obstetrics and Gynecology, University of Düsseldorf Medical Center, Moorenstrasse 5, 40225, Düsseldorf, Germany;
Department of Obstetrics and Gynecology, University of Düsseldorf Medical Center, Moorenstrasse 5, 40225, Düsseldorf, Germany;
Department of Obstetrics and Gynecology, University of Düsseldorf Medical Center, Moorenstrasse 5, 40225, Düsseldorf, Germany;
Department of Obstetrics and Gynecology, University of Düsseldorf Medical Center, Mooren;
Chemoresistant ovarian cancer; Murine model; Oncolytic adenovirus; Multidrug resistance;
机译:靶向MDR1的复制性腺病毒和化学疗法联合治疗卵巢癌。
机译:hase 2多西他赛,吉西他滨和奥沙利铂联合化疗在铂和紫杉醇预处理的上皮性卵巢癌中的试验
机译:多西他赛,吉西他滨和奥沙利铂联合化疗在铂和紫杉醇预处理的上皮性卵巢癌的2期试验
机译:大剂量化学疗法和自体干细胞拯救治疗的Theratope(STn-KLH)癌症疫苗治疗的乳腺癌和卵巢癌患者的临床结果:自体移植后的Theratope(STn-KLH)癌症疫苗
机译:整合基因组学和分子生物学:鉴定前列腺癌致癌基因SOX4的转录靶标并评估Aurora激酶抑制作用对化疗耐药的卵巢癌的疗效
机译:依托泊苷联合异环磷酰胺联合化疗对重度复发或持续性上皮性卵巢癌患者的回顾性研究
机译:依托皂苷和二聚石组合化疗的回顾性研究患有重预处理复发性或持续上皮卵巢癌的患者
机译:JO-1联合治疗与化疗在卵巢癌模型中的应用。